Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
170.39
Dollar change
-1.74
Percentage change
-1.01
%
IndexS&P 500 P/E50.73 EPS (ttm)3.36 Insider Own0.10% Shs Outstand1.77B Perf Week2.30%
Market Cap300.89B Forward P/E14.14 EPS next Y12.05 Insider Trans-20.73% Shs Float1.76B Perf Month4.58%
Income5.95B PEG8.16 EPS next Q3.05 Inst Own72.58% Short Float0.93% Perf Quarter-4.01%
Sales54.40B P/S5.53 EPS this Y1.15% Inst Trans0.10% Short Ratio3.19 Perf Half Y10.93%
Book/sh4.53 P/B37.57 EPS next Y7.25% ROA4.20% Short Interest16.49M Perf Year24.50%
Cash/sh10.23 P/C16.65 EPS next 5Y6.21% ROE55.92% 52W Range130.96 - 182.89 Perf YTD9.95%
Dividend Est.6.18 (3.63%) P/FCF13.77 EPS past 5Y-5.77% ROI8.29% 52W High-6.83% Beta0.62
Dividend TTM6.06 (3.56%) Quick Ratio0.83 Sales past 5Y11.76% Gross Margin68.99% 52W Low30.11% ATR (14)3.15
Dividend Ex-DateApr 12, 2024 Current Ratio0.94 EPS Y/Y TTM-21.01% Oper. Margin31.87% RSI (14)59.99 Volatility1.85% 1.95%
Employees50000 Debt/Eq9.24 Sales Y/Y TTM-4.12% Profit Margin10.94% Recom1.83 Target Price184.01
Option/ShortYes / Yes LT Debt/Eq7.97 EPS Q/Q496.96% Payout220.33% Rel Volume2.37 Prev Close172.13
Sales Surprise3.19% EPS Surprise2.24% Sales Q/Q0.70% EarningsApr 26 BMO Avg Volume5.17M Price170.39
SMA203.87% SMA503.98% SMA2006.55% Trades Volume12,229,993 Change-1.01%
Date Action Analyst Rating Change Price Target Change
Jun-05-24Upgrade HSBC Securities Hold → Buy $185
May-17-24Initiated Cantor Fitzgerald Overweight $200
Jan-29-24Upgrade William Blair Mkt Perform → Outperform
Dec-18-23Downgrade HSBC Securities Buy → Hold
Dec-11-23Upgrade Goldman Neutral → Buy
Nov-09-23Initiated Deutsche Bank Hold $150
Oct-30-23Upgrade Barclays Equal Weight → Overweight $160 → $170
Oct-20-23Resumed UBS Neutral $157 → $150
Sep-29-23Initiated Raymond James Outperform $177
Jul-25-23Initiated William Blair Mkt Perform
Jun-22-24 09:03AM
Jun-21-24 02:00PM
08:00AM
Jun-20-24 09:00AM
08:41AM
08:00AM Loading…
08:00AM
07:30AM
06:00AM
Jun-19-24 01:53PM
01:09PM
11:45AM
09:50AM
08:45AM
04:19AM
04:12AM
06:18PM Loading…
Jun-18-24 06:18PM
05:45PM
01:34PM
06:13AM
Jun-16-24 08:30AM
Jun-14-24 04:08PM
01:45PM
08:50AM
08:09AM
07:15AM
04:12AM
Jun-13-24 12:00PM
09:05AM
07:59AM
Jun-12-24 09:00AM
08:00AM Loading…
Jun-11-24 08:00AM
08:00AM
Jun-10-24 05:45PM
Jun-07-24 10:18AM
07:30AM
06:46AM
Jun-06-24 03:07PM
02:58PM
02:44PM
02:25PM
11:53AM
08:45AM
08:30AM
08:00AM
06:19AM
06:00AM
04:45AM
Jun-05-24 05:37PM
10:00AM
09:30AM
09:00AM
07:55AM
07:30AM
06:46AM
Jun-04-24 11:04AM
10:43AM
08:52AM
08:30AM
08:05AM
Jun-03-24 05:45PM
11:45AM
10:05AM
08:30AM
06:00AM
04:25AM
02:33AM
Jun-02-24 06:00AM
May-31-24 01:38PM
12:18PM
02:00AM
May-30-24 08:02AM
05:45AM
May-29-24 04:32PM
01:04PM
09:00AM
May-28-24 08:00AM
08:00AM
May-27-24 12:32PM
May-26-24 08:10AM
07:05AM
May-25-24 11:10PM
05:46AM
May-24-24 08:45AM
May-23-24 04:05PM
02:01PM
09:40AM
May-22-24 08:50PM
05:17PM
10:24AM
09:48AM
08:42AM
06:45AM
May-20-24 02:47PM
10:58AM
May-17-24 09:38AM
07:30AM
07:11AM
May-16-24 03:30PM
06:00AM
May-15-24 06:22AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERMar 20 '24Sale176.3021,0823,716,75755,903Mar 22 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Option Exercise61.3626,1101,602,110119,890Mar 20 05:00 PM
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERMar 18 '24Sale178.7958,94910,539,50860,941Mar 20 05:00 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Option Exercise61.3645,7002,804,15289,517Mar 05 05:30 PM
RICHMOND TIMOTHY J.EVP, CHIEF HR OFFICERMar 01 '24Sale177.2775,68013,415,50313,837Mar 05 05:30 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Option Exercise58.3021,5601,257,012167,524Mar 01 05:50 PM
Michael Robert A.PRES & CHIEF OPERATING OFFICERFeb 29 '24Sale176.4568,87912,153,95798,645Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 29 '24Sale177.399,8911,754,55510,397Mar 01 05:50 PM
Buckbee Kevin KSVP, CONTROLLERFeb 29 '24Sale176.655,144908,6886,983Mar 01 05:50 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOFeb 28 '24Sale177.27138,61624,572,458519,099Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Option Exercise137.3613,7531,889,11541,926Feb 27 05:10 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Option Exercise61.3614,140867,63041,205Mar 01 05:50 PM
Reents Scott TEVP, CHIEF FINANCIAL OFFICERFeb 23 '24Sale177.4414,1402,509,00227,065Mar 01 05:50 PM
Siatis Perry CEVP, GC AND SECRETARYFeb 23 '24Sale177.5113,7532,441,29528,173Feb 27 05:10 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Option Exercise58.8852,8703,112,986296,814Feb 23 05:00 PM
SALEKI-GERHARDT AZITAEVP, CHIEF OPERATIONS OFFICERFeb 21 '24Sale173.7152,8709,184,048243,944Feb 23 05:00 PM
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERDec 26 '23Sale154.722,912450,54555,903Dec 28 05:00 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOAug 01 '23Sale148.5860,0008,914,800565,294Aug 02 05:07 PM
GONZALEZ RICHARD ACHAIRMAN OF THE BOARD AND CEOJul 31 '23Sale149.1518,5002,759,275625,294Aug 02 05:07 PM